140
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Correlation Between Parathyroid Hormone Levels with Urinary Magnesium Excretion in Patients with Non-Dialysis Dependent Chronic Kidney Disease

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 341-348 | Published online: 19 Nov 2020

References

  • Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-0000723732715
  • Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 2018;94(2):315–325. doi:10.1016/j.kint.2018.02.02629861060
  • Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease—a review. Eur Heart J. 2004;25(20):1776–1787. doi:10.1016/j.ehj.2004.07.01015474692
  • Nieves JW. Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int. 2013;24(3):771–786. doi:10.1007/s00198-012-2214-423152094
  • Ahmed F, Mohammed A. Magnesium: the forgotten electrolyte - a review on hypomagnesemia. Med Sci. 2019;7(4):56. doi:10.3390/medsci7040056
  • Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr. 2013;4(3):378S–83S. doi:10.3945/an.112.00348323674807
  • Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1):i3–i14. doi:10.1093/ndtplus/sfr16326069819
  • Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015;10(7):1257–1272. doi:10.2215/CJN.0975091325287933
  • Žeravica R, Ilinčić B, Čabarkapa V, et al. Fractional excretion of magnesium and kidney function parameters in nondiabetic chronic kidney disease. Magnes Res. 2018;31(2):49–57. doi:10.1684/mrh.2018.043730398155
  • Gheissari A, Andalib A, Labibzadeh N, Modarresi M, Azhir A, Merrikhi A. Fractional excretion of magnesium (FEMg), a marker for tubular dysfunction in children with clinically recovered ischemic acute tubular necrosis. Saudi J Kidney Dis Transpl. 2011;22:476.21566303
  • Arnáiz AG, Bautista JAA, Montesdeoca JMS, Morenoy AMSMJ, Martel AC, León PB. Utilidad diagnóstica del cuestionario alcohol use disorders identification test (AUDIT) para detectar el consumo de alcohol de riesgo en atención primaria. Med Clin. 2001;116(4):121–124. doi:10.1016/S0025-7753(01)71745-9
  • Williams B, Mancia G, Spiering W, et al. ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH). Eur Heart J. 2018;39:3021–3104.30165516
  • Vendrame S, Scattolini M, Brito VP. Hipomagnesemia In: Lopes RD, editor. Equilíbrio Ácido-Base e Hidroeletrolítico. São Paulo: Atheneu; 2009:171–178.
  • Levin A, Stevens PE, Bilous RW, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
  • Levy AR, Perkins RM, Johnston KM, et al. An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7:271. doi:10.2147/IJNRD.S5807425061330
  • World Health Organization (WHO). Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. Geneva; 2000.
  • Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994;21:55–67.8197257
  • Glasdam SM, Glasdam S, Peters GH. The importance of magnesium in the human body. Adv Clin Chem. 2016;169–193.26975973
  • Martin KJ, Gonzalez EA, Slatopolsky E. Clinical consequences and management of hypomagnesemia. Clin J Am Soc Nephrol. 2009;20(11):2291–2295. doi:10.1681/ASN.2007111194
  • Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA. Magnesium transport in the renal distal convoluted tubule. Physiol Rev. 2001;81(1):51–84. doi:10.1152/physrev.2001.81.1.5111152754
  • Noiri C, Shimizu T, Takayanagi K, et al. Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters. Clin Exp Nephrol. 2015;19(6):1071–1078. doi:10.1007/s10157-015-1099-x25724126
  • Cole DC, Quamme GA. Inherited disorders of renal magnesium handling. J Am Soc Nephrol. 2000;11:1937–1947.11004227
  • Vormann J. Magnesium: nutrition and metabolism. Mol Aspects Med. 2003;24(1–3):27–37. doi:10.1016/S0098-2997(02)00089-412537987
  • Felsenfeld AJ, Levine BS, Rodriguez M. Pathophysiology of calcium, phosphate, and magnesium dysregulation in chronic kidney disease. Semin Dial. 2015;28(6):564–577. doi:10.1111/sdi.1241126303319
  • Navarro-Gonzales JF, Mora-Fernandez C, Garcia-Perez J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial. 2009;22(1):37–44. doi:10.1111/j.1525-139X.2008.00530.x19250445
  • Cunningham J, Rodríguez M, Messa P. Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J. 2012;5(Suppl 1):i39–i51. doi:10.1093/ndtplus/sfr16626069820
  • Azem R, Daou R, Bassil E, et al. Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020;21(1):49. doi:10.1186/s12882-020-1713-332050924
  • de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiological reviews. 2015;95(1):1–46. doi:10.1152/physrev.00012.201425540137
  • Deekajorndech T. A biomarker for detecting early tubulointerstitial disease and ischemia in glomerulonephropathy. Renal Failure. 2007;29:1013–1017. doi:10.1080/0886022070164356718067049
  • Futrakul N, Futrakul P. Biomarker for early renal microvascular and diabetic kidney diseases. Renal Failure. 2017;39(1):505–511. doi:10.1080/0886022X.2017.132364728494191
  • Quamme GA. Laboratory evaluation of magnesium studies: renal function and free intracellular magnesium concentration. Clinics in Laboratory Medicine. 1993;13:209–223. doi:10.1016/S0272-2712(18)30470-08462261
  • Taliercio JJ, Schold JD, Simon JF, et al. Prognostic importance of serum alkaline phosphatase in CKD stages 3–4 in a clinical population. American Journal of Kidney Diseases. 2013;62:703–710. doi:10.1053/j.ajkd.2013.04.01223769134
  • Bover J, Ureña P, Aguilar A, et al. Alkaline phosphatases in the complex chronic kidney disease-mineral and bone disorders. Calcified Tissue International. 2018;103:111–124. doi:10.1007/s00223-018-0399-z29445837
  • Behets J, Spasovski G, Sterling R, et al. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney International. 2015;87:846–848. doi:10.1038/ki.2014.34925337774
  • Căpuşă C, Chirculescu B, Vladu I, et al. The prevalence of biochemical abnormalities of chronic kidney disease. Mineral and bone disorders in untreated non-dialysis patients–a multicenter study. Acta Endocrinologica. 2016;12:282. doi:10.4183/aeb.2016.28231149102
  • Anderson JL, Vanwoerkom RC, Horne BD, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? American Heart Journal. 2011;162:331–339. doi:10.1016/j.ahj.2011.05.00521835295
  • Koc H, Hoser H, Akdag Y, Kendir C, Ersoy FF. Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study. International Urology and Nephrology. 2019;51:1261–1270. doi:10.1007/s11255-019-02175-531161518
  • Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clinical Journal of the American Society of Nephrology. 2015;10:98–109. doi:10.2215/CJN.1294121325516917
  • Chandran M, Wong J. Secondary and tertiary hyperparathyroidism in chronic kidney disease: an endocrine and renal perspective. Indian Journal of Endocrinology and Metabolism. 2019;23:391. doi:10.4103/ijem.IJEM_292_1931741895
  • Vieth R, Yasmin L, Paul GW. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. Journal of Clinical Endocrinology and Metabolism. 2003;88:185–191. doi:10.1210/jc.2002-02106412519850
  • Yataru S, Youngberg B, Zdunek S. Vitamin D levels in subjects with or without chronic kidney disease among veterans with diabetes in North East United States. World Journal of Diabetes. 2017;8(7):346–350. doi:10.4239/wjd.v8.i7.34628751957
  • Cuppari L, Carvalho AB, Draibe SA. Vitamin D status of chronic kidney disease patients living in a sunny country. Journal of Renal Nutrition. 2008;18(5):408–414. doi:10.1053/j.jrn.2008.05.00418721735
  • Petchey WG, Johnson DW, Hawley CM, Isbel NM. Predictors of vitamin D status in predialysis chronic kidney disease patients: a cross-sectional analysis in a high ultraviolet climate. Journal of Renal Nutrition. 2012;22:400–408. doi:10.1053/j.jrn.2011.08.00722074789